♥
ISIN : INE092A01019
NSE : TATACHEM
BSE : 500770
Face Value : 10
Industry : Chemicals
EPS : 11.07
EPS (TTM) : -13.35
Price to Earning (P/E) : 78.13
Book Value : 872.20
Price to Bookvalue (P/B) : 0.99
Dividend Yield : 2 %
Return on Equity (ROE) : 2.14 %
Return on Capital Employed (ROCE) : 5.12 %
Tata Chemicals Limited
ISIN : INE092A01019
NSE : TATACHEM
BSE : 500770
Face Value : 10
Industry : Chemicals
EPS : 11.07
EPS (TTM) : -13.35
Price to Earning (P/E) : 78.13
Book Value : 872.20
Price to Bookvalue (P/B) : 0.99
Dividend Yield : 2 %
Return on Equity (ROE) : 2.14 %
Return on Capital Employed (ROCE) : 5.12 %
Tata Chemicals share price(02-Apr-2026) | |
|---|---|
| Open / Close | 0 - 0 NAN % |
| Low / High | 0 - 0 NAN % |
| Trade Volume | 0 |
| 52 Week Low / High | 0 - 0 NAN % |
| Open / Close | 599.05 - 652.6 8.9 % |
| Low / High | 592.25 - 675.95 14.1 % |
| Trade Volume | 5.73 Lk |
| 52 Week Low / High | 581.3 - 1026 76.5 % |
-
YOU MAY ALSO LIKE
- Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE - How much money do you need to retire
Know how much money do you need to retire, before how much to invest ? - Share Market basics for beginners
Share Market jargons in simple terms - CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator - High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE - Stock market course tutorial
Stock Market Investment Course explained in simple words.
CONSOLIDATED QUARTERLY RESULT FOR TATA CHEMICALS LIMITED
| Date End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 39950 | 42390 | 41480 | 44070 | 42180 | 39980 | 37300 | 34750 | 37890 | 39990 |
| Total Income | 40410 | 42990 | 41850 | 44820 | 42670 | 40830 | 37680 | 35890 | 38360 | 41070 |
| Total Expenditure | 29800 | 33190 | 32260 | 34420 | 31750 | 31790 | 31880 | 30320 | 32150 | 33810 |
| Other Income | 460 | 600 | 370 | 750 | 490 | 850 | 380 | 1140 | 470 | 1080 |
| Operating Profit | 10610 | 9800 | 9590 | 10400 | 10920 | 9040 | 5800 | 5570 | 6210 | 7260 |
| Interest | 800 | 860 | 1070 | 1330 | 1230 | 1450 | 1320 | 1300 | 1330 | 1450 |
| Exceptional Items | 1020 | -9630 | ||||||||
| PBDT | 9810 | 8940 | 8520 | 9070 | 9690 | 8610 | 4480 | -5360 | 4880 | 5810 |
| Depreciation | 2130 | 2180 | 2270 | 2340 | 2290 | 2340 | 2460 | 2710 | 2730 | 2770 |
| Profit Before Tax | 7680 | 6760 | 6250 | 6730 | 7400 | 6270 | 2020 | -8070 | 2150 | 3040 |
| Tax | 1560 | 380 | 1020 | -80 | 1710 | 1200 | 680 | 220 | 940 | 810 |
| Profit After Tax | 6120 | 6380 | 5230 | 6810 | 5690 | 5070 | 1340 | -8290 | 1210 | 2230 |
| Net Profit | 6080 | 6330 | 5160 | 6790 | 5780 | 5070 | 1340 | -8520 | 1360 | 2230 |
| Equity Capital | 2550 | 2550 | 2550 | 2550 | 2550 | 2550 | 2550 | 2550 | 2550 | 2550 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | 23.1 | 24.63 | 15.33 | 27.8 | 20.86 | 16.78 | 6.2 | -33.33 | 5.88 | 7.61 |
| Diluted Eps After Extraordinary Items | 23.28 | 24.85 | 15.62 | 27.91 | 20.53 | 16.8 | 6.2 | -32.46 | 5.3 | 7.61 |
| Diluted Eps Before Extraordinary Items | 23.28 | 24.85 | 15.62 | 27.91 | 20.53 | 16.8 | 6.2 | -32.46 | 5.3 | 7.61 |
STANDALONE QUARTERLY RESULT FOR TATA CHEMICALS LIMITED
| Date End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 12250 | 11850 | 12180 | 13020 | 11350 | 10660 | 10930 | 10900 | 10470 | 10090 |
| Total Income | 13860 | 12360 | 12440 | 13650 | 13290 | 11350 | 11150 | 11880 | 12340 | 11040 |
| Total Expenditure | 8270 | 8910 | 9340 | 10430 | 8460 | 8780 | 8870 | 8980 | 8120 | 8650 |
| Other Income | 1610 | 510 | 260 | 630 | 1940 | 690 | 220 | 980 | 1870 | 950 |
| Operating Profit | 5590 | 3450 | 3100 | 3220 | 4830 | 2570 | 2280 | 2900 | 4220 | 2390 |
| Interest | 40 | 80 | 40 | 100 | 110 | 150 | 120 | 110 | 130 | 320 |
| Exceptional Items | 1020 | |||||||||
| PBDT | 5550 | 3370 | 3060 | 3120 | 4720 | 3440 | 2160 | 2790 | 4090 | 2070 |
| Depreciation | 600 | 600 | 620 | 630 | 660 | 710 | 760 | 820 | 870 | 900 |
| Profit Before Tax | 4950 | 2770 | 2440 | 2490 | 4060 | 2730 | 1400 | 1970 | 3220 | 1170 |
| Tax | 1140 | 340 | 540 | 360 | 780 | 370 | 250 | -200 | 660 | 180 |
| Profit After Tax | 3810 | 2430 | 1900 | 2130 | 3280 | 2360 | 1150 | 2170 | 2560 | 990 |
| Net Profit | 3810 | 2430 | 1900 | 2130 | 3280 | 2360 | 1150 | 2170 | 2710 | 990 |
| Equity Capital | 2550 | 2550 | 2550 | 2550 | 2550 | 2550 | 2550 | 2550 | 2550 | 2550 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | 14.94 | 9.53 | 7.45 | 8.35 | 12.86 | 9.25 | 4.51 | 8.51 | 10.04 | 3.88 |
| Diluted Eps After Extraordinary Items | 14.96 | 9.54 | 7.46 | 8.35 | 12.88 | 9.26 | 4.51 | 8.51 | 10.05 | 3.89 |
| Diluted Eps Before Extraordinary Items | 14.96 | 9.54 | 7.46 | 8.35 | 12.88 | 9.26 | 4.51 | 8.51 | 10.05 | 3.89 |
CONSOLIDATED ANNUAL RESULT FOR TATA CHEMICALS LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 126221 | 167890 | 154210 |
| Total Income | 128781 | 170070 | 157070 |
| Total Expenditure | 103175 | 129670 | 125740 |
| Other Income | 2559.8 | 2180 | 2860 |
| Operating Profit | 25606.1 | 40400 | 31330 |
| Interest | 3028.4 | 4060 | 5300 |
| Exceptional Items | -110.4 | -8610 | |
| PBDT | 22467.3 | 36340 | 17420 |
| Depreciation | 8061.2 | 8920 | 9800 |
| Profit Before Tax | 14406.1 | 27420 | 7620 |
| Tax | 2664.8 | 2880 | 3810 |
| Profit After Tax | 11741.3 | 24540 | 3810 |
| Net Profit | 11791.1 | 24360 | 3670 |
| Equity Capital | 2548.2 | 2550 | 2550 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 189026 | 203870 | 228590 |
| Calculated EPS | 49.35 | 90.86 | 10.51 |
| Diluted Eps After Extraordinary Items | 49.37 | 91.66 | 11.07 |
| Diluted Eps Before Extraordinary Items | 49.37 | 91.66 | 11.07 |
STANDALONE ANNUAL RESULT FOR TATA CHEMICALS LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 37209.3 | 49300 | 43840 |
| Total Income | 39988.6 | 52310 | 47670 |
| Total Expenditure | 27695.6 | 36950 | 35090 |
| Other Income | 2779.3 | 3010 | 3830 |
| Operating Profit | 12293 | 15360 | 12580 |
| Interest | 192.8 | 260 | 490 |
| Exceptional Items | 1020 | ||
| PBDT | 12100.2 | 15100 | 13110 |
| Depreciation | 2224.1 | 2450 | 2950 |
| Profit Before Tax | 9876.1 | 12650 | 10160 |
| Tax | 2011.1 | 2380 | 1200 |
| Profit After Tax | 7865 | 10270 | 8960 |
| Net Profit | 8015.6 | 10270 | 8960 |
| Equity Capital | 2548.2 | 2550 | 2550 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 150875 | 157370 | 184700 |
| Calculated EPS | 30.86 | 40.27 | 35.14 |
| Diluted Eps After Extraordinary Items | 31.46 | 40.31 | 35.17 |
| Diluted Eps Before Extraordinary Items | 31.46 | 40.31 | 35.17 |
CONSOLIDATED PROFIT / LOSS FOR TATA CHEMICALS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 11030.2 Cr | 13358.5 Cr | 17683 Cr | 16451 Cr |
| Sales | 10919.2 Cr | 13253.5 Cr | 17574 Cr | 16332 Cr |
| Net Sales | 10199.8 Cr | 12622.1 Cr | 16789 Cr | 15421 Cr |
| Increase/Decrease in Stock | -7.09 Cr | -122.56 Cr | -28 Cr | -241 Cr |
| Raw Material Consumed | 2404.01 Cr | 2759.87 Cr | 3311 Cr | 2942 Cr |
| Opening Raw Materials | 740.59 Cr | 542.42 Cr | 994 Cr | 1143 Cr |
| Purchases Raw Materials | 1882.99 Cr | 2875.06 Cr | 3096 Cr | 2498 Cr |
| Closing Raw Materials | 542.42 Cr | 993.57 Cr | 1143 Cr | 931 Cr |
| Other Direct Purchases / Brought in cost | 322.85 Cr | 335.96 Cr | 364 Cr | 232 Cr |
| Power & Fuel Cost | 1437.09 Cr | 2112.19 Cr | 2988 Cr | 2673 Cr |
| Electricity & Power | 1437.09 Cr | 2112.19 Cr | 2988 Cr | 2673 Cr |
| Employee Cost | 1399.74 Cr | 1540 Cr | 1691 Cr | 1860 Cr |
| Salaries, Wages & Bonus | 1097.58 Cr | 1222.21 Cr | 1337 Cr | 1471 Cr |
| Contributions to EPF & Pension Funds | 141.14 Cr | 148.72 Cr | 130 Cr | 141 Cr |
| Workmen and Staff Welfare Expenses | 161.02 Cr | 169.07 Cr | 224 Cr | 248 Cr |
| Other Manufacturing Expenses | 1210.16 Cr | 1458.97 Cr | 1777 Cr | 1887 Cr |
| Repairs and Maintenance | 421.05 Cr | 447.78 Cr | 593 Cr | 732 Cr |
| Packing Material Consumed | 227.39 Cr | 318.98 Cr | 318 Cr | 276 Cr |
| General and Administration Expenses | 131.59 Cr | 143.46 Cr | 166 Cr | 182 Cr |
| Rent , Rates & Taxes | 51.92 Cr | 43.49 Cr | 50 Cr | 42 Cr |
| Insurance | 63.17 Cr | 82.31 Cr | 91 Cr | 107 Cr |
| Selling and Distribution Expenses | 1538.4 Cr | 1882.78 Cr | 2319 Cr | 2378 Cr |
| Advertisement & Sales Promotion | 81.22 Cr | 76.52 Cr | 135 Cr | 110 Cr |
| Freight and Forwarding | 1457.18 Cr | 1806.26 Cr | 2184 Cr | 2268 Cr |
| Miscellaneous Expenses | 585.26 Cr | 546.73 Cr | 743 Cr | 893 Cr |
| Bad debts /advances written off | 17 Lk | 17.45 Cr | 3 Cr | 11 Cr |
| Provision for doubtful debts | 8.12 Cr | 0 | 6 Cr | 12 Cr |
| Loss on disposal of fixed assets(net) | 5.79 Cr | 14.08 Cr | 28 Cr | 12 Cr |
| Loss on foreign exchange fluctuations | 23.88 Cr | 6.6 Cr | 30 Cr | 47 Cr |
| Total Expenditure | 8699.16 Cr | 10321.4 Cr | 12967 Cr | 12574 Cr |
| Other Income | 234.42 Cr | 259.93 Cr | 218 Cr | 286 Cr |
| Interest Received | 74.76 Cr | 115.29 Cr | 75 Cr | 141 Cr |
| Dividend Received | 20.12 Cr | 25.93 Cr | 41 Cr | 49 Cr |
| Profits on sale of Investments | 61 Cr | 57.65 Cr | 57 Cr | 49 Cr |
| Provision Written Back | 0 | 3.95 Cr | 0 | 0 |
| Operating Profit | 1735.06 Cr | 2560.61 Cr | 4040 Cr | 3133 Cr |
| Interest | 367.37 Cr | 302.84 Cr | 406 Cr | 530 Cr |
| InterestonDebenture / Bonds | 276.59 Cr | 0 | 0 | 0 |
| Interest on Term Loan | 0 | 219.29 Cr | 315 Cr | 400 Cr |
| Bank Charges etc | 0 | 75.61 Cr | 81 Cr | 100 Cr |
| PBDT | 1367.69 Cr | 2257.77 Cr | 3634 Cr | 2603 Cr |
| Depreciation | 759.32 Cr | 806.12 Cr | 892 Cr | 980 Cr |
| Profit Before Taxation & Exceptional Items | 608.37 Cr | 1451.65 Cr | 2742 Cr | 1623 Cr |
| Exceptional Income / Expenses | 0 | -11.04 Cr | 0 | -861 Cr |
| Profit Before Tax | 608.37 Cr | 1440.61 Cr | 2740 Cr | 830 Cr |
| Provision for Tax | 197.77 Cr | 266.48 Cr | 288 Cr | 381 Cr |
| Current Income Tax | 225.79 Cr | 297.15 Cr | 409 Cr | 345 Cr |
| Deferred Tax | -28.02 Cr | -7.85 Cr | -86 Cr | 121 Cr |
| Profit After Tax | 410.6 Cr | 1174.13 Cr | 2452 Cr | 449 Cr |
| Extra items | 0 | 4.98 Cr | -18 Cr | -14 Cr |
| Minority Interest | -179.85 Cr | -147.51 Cr | -117 Cr | -167 Cr |
| Share of Associate | 25.62 Cr | 226.02 Cr | 0 | 0 |
| Consolidated Net Profit | 256.37 Cr | 1257.62 Cr | 2317 Cr | 268 Cr |
| Profit Balance B/F | 6185.8 Cr | 6254.08 Cr | 7616 Cr | 9582 Cr |
| Appropriations | 6442.17 Cr | 7511.7 Cr | 9933 Cr | 9850 Cr |
| Other Appropriation | 188.09 Cr | -103.83 Cr | 351 Cr | 592 Cr |
| Equity Dividend % | 100 | 125 | 175 | 150 |
| Earnings Per Share | 10.06 | 49.36 | 90.86 | 10.51 |
| Adjusted EPS | 10.06 | 49.36 | 90.86 | 10.51 |
STANDALONE PROFIT / LOSS FOR TATA CHEMICALS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 3136.24 Cr | 3822.73 Cr | 5003 Cr | 4534 Cr |
| Sales | 3121.62 Cr | 3809.27 Cr | 4988 Cr | 4510 Cr |
| Net Sales | 2998.88 Cr | 3720.93 Cr | 4930 Cr | 4384 Cr |
| Increase/Decrease in Stock | 11.59 Cr | -42.95 Cr | -107 Cr | 24 Cr |
| Raw Material Consumed | 752.89 Cr | 974.49 Cr | 1268 Cr | 1089 Cr |
| Opening Raw Materials | 455.62 Cr | 290.61 Cr | 635 Cr | 860 Cr |
| Purchases Raw Materials | 435.32 Cr | 1158.44 Cr | 1363 Cr | 792 Cr |
| Closing Raw Materials | 290.61 Cr | 634.91 Cr | 860 Cr | 649 Cr |
| Other Direct Purchases / Brought in cost | 152.56 Cr | 160.35 Cr | 130 Cr | 86 Cr |
| Power & Fuel Cost | 488.75 Cr | 670.22 Cr | 1188 Cr | 1015 Cr |
| Electricity & Power | 488.75 Cr | 670.22 Cr | 1188 Cr | 1015 Cr |
| Employee Cost | 250.42 Cr | 248.46 Cr | 274 Cr | 299 Cr |
| Salaries, Wages & Bonus | 183.5 Cr | 192.98 Cr | 197 Cr | 231 Cr |
| Contributions to EPF & Pension Funds | 30.95 Cr | 16.05 Cr | 16 Cr | 17 Cr |
| Workmen and Staff Welfare Expenses | 35.97 Cr | 39.43 Cr | 61 Cr | 51 Cr |
| Other Manufacturing Expenses | 297.85 Cr | 347.82 Cr | 332 Cr | 332 Cr |
| Repairs and Maintenance | 70.2 Cr | 76.51 Cr | 94 Cr | 101 Cr |
| Packing Material Consumed | 90.63 Cr | 125.12 Cr | 125 Cr | 108 Cr |
| General and Administration Expenses | 32.34 Cr | 35.83 Cr | 34 Cr | 35 Cr |
| Rent , Rates & Taxes | 7.43 Cr | 6.29 Cr | 9 Cr | 6 Cr |
| Insurance | 13.98 Cr | 17.07 Cr | 18 Cr | 20 Cr |
| Selling and Distribution Expenses | 425.13 Cr | 463.22 Cr | 530 Cr | 520 Cr |
| Advertisement & Sales Promotion | 1.97 Cr | 3.62 Cr | 3 Cr | 6 Cr |
| Freight and Forwarding | 423.16 Cr | 459.6 Cr | 527 Cr | 514 Cr |
| Miscellaneous Expenses | 129.03 Cr | 78.8 Cr | 995 Cr | 202 Cr |
| Bad debts /advances written off | 13 Lk | 6.66 Cr | 818 Cr | 9 Cr |
| Provision for doubtful debts | 5 Lk | 0 | 0 | 0 |
| Loss on disposal of fixed assets(net) | 2.78 Cr | 4 Cr | 5 Cr | 1 Cr |
| Loss on foreign exchange fluctuations | 4.15 Cr | 0 | 3 Cr | 9 Cr |
| Total Expenditure | 2388 Cr | 2775.89 Cr | 4514 Cr | 3516 Cr |
| Other Income | 219.15 Cr | 284.26 Cr | 1120 Cr | 390 Cr |
| Interest Received | 65.76 Cr | 110.41 Cr | 61 Cr | 107 Cr |
| Dividend Received | 72.91 Cr | 82.95 Cr | 162 Cr | 209 Cr |
| Profits on sale of Investments | 45.82 Cr | 45.85 Cr | 54 Cr | 42 Cr |
| Provision Written Back | 0 | 6.33 Cr | 819 Cr | 4 Cr |
| Foreign Exchange Gains | 0 | 5.33 Cr | 0 | 0 |
| Operating Profit | 830.03 Cr | 1229.3 Cr | 1536 Cr | 1258 Cr |
| Interest | 18.74 Cr | 19.28 Cr | 26 Cr | 49 Cr |
| InterestonDebenture / Bonds | 1 Lk | 0 | 0 | 0 |
| Interest on Term Loan | 0 | 1 Lk | 0 | 13 Cr |
| Bank Charges etc | 0 | 18.49 Cr | 26 Cr | 27 Cr |
| PBDT | 811.29 Cr | 1210.02 Cr | 1510 Cr | 1209 Cr |
| Depreciation | 197.32 Cr | 222.41 Cr | 245 Cr | 295 Cr |
| Profit Before Taxation & Exceptional Items | 613.97 Cr | 987.61 Cr | 1265 Cr | 914 Cr |
| Exceptional Income / Expenses | 0 | 0 | 0 | 102 Cr |
| Profit Before Tax | 613.97 Cr | 987.61 Cr | 1265 Cr | 1016 Cr |
| Provision for Tax | 134.86 Cr | 201.11 Cr | 238 Cr | 120 Cr |
| Current Income Tax | 134.49 Cr | 232.13 Cr | 274 Cr | 143 Cr |
| Deferred Tax | 37 Lk | -2.9 Cr | -1 Cr | 56 Cr |
| Profit After Tax | 479.11 Cr | 786.5 Cr | 1027 Cr | 896 Cr |
| Extra items | 0 | 15.06 Cr | 0 | 0 |
| Consolidated Net Profit | 479.11 Cr | 801.56 Cr | 1027 Cr | 896 Cr |
| Profit Balance B/F | 5859.58 Cr | 6078.31 Cr | 6642 Cr | 7357 Cr |
| Appropriations | 6338.69 Cr | 6879.87 Cr | 7669 Cr | 8253 Cr |
| Other Appropriation | 260.38 Cr | 237.66 Cr | 312 Cr | 455 Cr |
| Equity Dividend % | 100 | 125 | 175 | 150 |
| Earnings Per Share | 18.81 | 30.87 | 40.27 | 35.14 |
| Adjusted EPS | 18.81 | 30.87 | 40.27 | 35.14 |
CONSOLIDATED CASH FLOW FOR TATA CHEMICALS LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 633.99 Cr | 1684.92 Cr | 2722 Cr | 816 Cr |
| Adjustment | 1176.33 Cr | 871.59 Cr | 1335 Cr | 2255 Cr |
| Changes In working Capital | 323.31 Cr | -648.83 Cr | -679 Cr | 332 Cr |
| Cash Flow after changes in Working Capital | 2133.63 Cr | 1907.68 Cr | 3378 Cr | 3403 Cr |
| Cash Flow from Operating Activities | 2037.3 Cr | 1644.33 Cr | 2971 Cr | 3016 Cr |
| Cash Flow from Investing Activities | -1130.31 Cr | -836.14 Cr | -1186 Cr | -610 Cr |
| Cash Flow from Financing Activitie | -1455.65 Cr | -755.25 Cr | -2076 Cr | -2494 Cr |
| Net Cash Inflow / Outflow | -548.66 Cr | 52.94 Cr | -291 Cr | -88 Cr |
| Opening Cash & Cash Equivalents | 1254.26 Cr | 689.34 Cr | 762 Cr | 508 Cr |
| Effect of Foreign Exchange Fluctuations | -16.26 Cr | 19.25 Cr | 37 Cr | 5 Cr |
| Closing Cash & Cash Equivalent | 689.34 Cr | 761.53 Cr | 508 Cr | 425 Cr |
STANDALONE CASH FLOW FOR TATA CHEMICALS LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 613.97 Cr | 1015.98 Cr | 1265 Cr | 1016 Cr |
| Adjustment | 91.02 Cr | 20.91 Cr | 44 Cr | -88 Cr |
| Changes In working Capital | 117.82 Cr | -269.48 Cr | -143 Cr | 28 Cr |
| Cash Flow after changes in Working Capital | 822.81 Cr | 767.41 Cr | 1166 Cr | 956 Cr |
| Cash Flow from Operating Activities | 671.75 Cr | 581.75 Cr | 885 Cr | 806 Cr |
| Cash Flow from Investing Activities | -402.8 Cr | -355.15 Cr | -558 Cr | -351 Cr |
| Cash Flow from Financing Activitie | -291.26 Cr | -270.25 Cr | -332 Cr | -458 Cr |
| Net Cash Inflow / Outflow | -22.31 Cr | -43.65 Cr | -5 Cr | -3 Cr |
| Opening Cash & Cash Equivalents | 83.72 Cr | 61.41 Cr | 18 Cr | 13 Cr |
| Closing Cash & Cash Equivalent | 61.41 Cr | 17.76 Cr | 13 Cr | 10 Cr |
CONSOLIDATED BALANCE SHEET FOR TATA CHEMICALS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 254.82 Cr | 254.82 Cr | 255 Cr | 255 Cr |
| Equity - Authorised | 270 Cr | 270 Cr | 270 Cr | 270 Cr |
| Equity - Issued | 254.84 Cr | 254.84 Cr | 255 Cr | 255 Cr |
| Equity Paid Up | 254.76 Cr | 254.76 Cr | 255 Cr | 255 Cr |
| Equity Shares Forfeited | 6 Lk | 6 Lk | 0 | 0 |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 14035.2 Cr | 17998.1 Cr | 19466 Cr | 21986 Cr |
| Securities Premium | 1258.89 Cr | 1258.89 Cr | 1259 Cr | 1259 Cr |
| Capital Reserves | 326.64 Cr | 326.64 Cr | 327 Cr | 327 Cr |
| Profit & Loss Account Balance | 6254.08 Cr | 7615.53 Cr | 9582 Cr | 9258 Cr |
| General Reserves | 1522.47 Cr | 1522.47 Cr | 1522 Cr | 1522 Cr |
| Reserve excluding Revaluation Reserve | 14035.2 Cr | 17998.1 Cr | 19466 Cr | 21986 Cr |
| Shareholder's Funds | 14290 Cr | 18252.9 Cr | 19721 Cr | 22241 Cr |
| Minority Interest | 852.6 Cr | 904.5 Cr | 921 Cr | 873 Cr |
| Secured Loans | 3370.78 Cr | 3170.85 Cr | 3336 Cr | 2593 Cr |
| Term Loans - Banks | 3370.68 Cr | 4284.32 Cr | 3553 Cr | 2772 Cr |
| Unsecured Loans | 1828.7 Cr | 554.61 Cr | 2204 Cr | 305 Cr |
| Long Term Loan in Foreign Currency | 0 | 0 | 0 | 2202 Cr |
| Loans - Banks | 1824.02 Cr | 2285.68 Cr | 2426 Cr | 0 |
| Loans - Others | 4.68 Cr | 4.68 Cr | 4 Cr | 0 |
| Deferred Tax Assets / Liabilities | 1572.11 Cr | 2036.33 Cr | 1791 Cr | 2330 Cr |
| Deferred Tax Assets | 93.71 Cr | 55.98 Cr | 199 Cr | 198 Cr |
| Deferred Tax Liability | 1665.82 Cr | 2092.31 Cr | 1990 Cr | 2528 Cr |
| Other Long Term Liabilities | 361.59 Cr | 548.66 Cr | 609 Cr | 849 Cr |
| Long Term Provisions | 1598.09 Cr | 1279.28 Cr | 1454 Cr | 1465 Cr |
| Total Non-Current Liabilities | 8731.27 Cr | 7589.73 Cr | 9394 Cr | 7542 Cr |
| Trade Payables | 1682.87 Cr | 2444.68 Cr | 2597 Cr | 2369 Cr |
| Sundry Creditors | 1682.87 Cr | 2444.68 Cr | 2384 Cr | 2073 Cr |
| Acceptances | 0 | 0 | 213 Cr | 296 Cr |
| Other Current Liabilities | 1982.85 Cr | 3930.06 Cr | 1736 Cr | 3332 Cr |
| Advances received from customers | 113.63 Cr | 143.85 Cr | 118 Cr | 349 Cr |
| Interest Accrued But Not Due | 34.49 Cr | 19.67 Cr | 9 Cr | 0 |
| Current maturity - Others | 91.98 Cr | 0 | 0 | 0 |
| Short Term Borrowings | 277.58 Cr | 227.85 Cr | 100 Cr | 88 Cr |
| Secured ST Loans repayable on Demands | 44.26 Cr | 53.96 Cr | 100 Cr | 20 Cr |
| Working Capital Loans- Sec | 44.26 Cr | 53.96 Cr | 100 Cr | 20 Cr |
| Buyers Credits - Unsec | 28.61 Cr | 0 | 0 | 0 |
| Short Term Provisions | 520.06 Cr | 493.44 Cr | 471 Cr | 266 Cr |
| Provision for Tax | 154.93 Cr | 122.26 Cr | 119 Cr | 33 Cr |
| Provision for post retirement benefits | 20.42 Cr | 72.82 Cr | 76 Cr | 81 Cr |
| Total Current Liabilities | 4463.36 Cr | 7096.03 Cr | 4904 Cr | 6055 Cr |
| Total Liabilities | 28337.2 Cr | 33843.1 Cr | 34940 Cr | 36711 Cr |
| Gross Block | 18628.5 Cr | 20111.4 Cr | 21970 Cr | 24341 Cr |
| Less: Accumulated Depreciation | 3422.34 Cr | 4121.01 Cr | 4930 Cr | 6532 Cr |
| Net Block | 15206.2 Cr | 15990.4 Cr | 17040 Cr | 17809 Cr |
| Capital Work in Progress | 1034.71 Cr | 1589.56 Cr | 2351 Cr | 2165 Cr |
| Non Current Investments | 4307.19 Cr | 6411.14 Cr | 6178 Cr | 9124 Cr |
| Long Term Investment | 4307.19 Cr | 6411.14 Cr | 6178 Cr | 9124 Cr |
| Quoted | 2784.31 Cr | 4504.81 Cr | 4364 Cr | 6939 Cr |
| Unquoted | 1522.88 Cr | 1906.33 Cr | 1814 Cr | 2185 Cr |
| Long Term Loans & Advances | 975.22 Cr | 875.76 Cr | 983 Cr | 1043 Cr |
| Other Non Current Assets | 109.4 Cr | 153.5 Cr | 113 Cr | 99 Cr |
| Total Non-Current Assets | 21691.5 Cr | 25098.1 Cr | 26776 Cr | 30344 Cr |
| Currents Investments | 1563.49 Cr | 1325.06 Cr | 1270 Cr | 615 Cr |
| Quoted | 0 | 0 | 39 Cr | 0 |
| Unquoted | 1522.88 Cr | 1906.33 Cr | 1814 Cr | 2185 Cr |
| Inventories | 1686.56 Cr | 2293.53 Cr | 2532 Cr | 2524 Cr |
| Raw Materials | 542.42 Cr | 993.57 Cr | 1143 Cr | 931 Cr |
| Work-in Progress | 115.12 Cr | 186.4 Cr | 203 Cr | 195 Cr |
| Finished Goods | 676.88 Cr | 775.6 Cr | 806 Cr | 996 Cr |
| Stores and Spare | 257.84 Cr | 286.6 Cr | 313 Cr | 328 Cr |
| Sundry Debtors | 1396.99 Cr | 1933.35 Cr | 2627 Cr | 1900 Cr |
| Debtors more than Six months | 90.99 Cr | 99.22 Cr | 107 Cr | 110 Cr |
| Debtors Others | 1396.99 Cr | 1921.88 Cr | 2615 Cr | 1898 Cr |
| Cash and Bank | 1411.01 Cr | 1310.38 Cr | 665 Cr | 645 Cr |
| Cash in hand | 5 Lk | 6 Lk | 0 | 0 |
| Balances at Bank | 1410.96 Cr | 1310.32 Cr | 665 Cr | 645 Cr |
| Other Current Assets | 528.53 Cr | 1836.82 Cr | 689 Cr | 591 Cr |
| Prepaid Expenses | 71.96 Cr | 107.96 Cr | 119 Cr | 154 Cr |
| Short Term Loans and Advances | 59.13 Cr | 45.87 Cr | 377 Cr | 83 Cr |
| Advances recoverable in cash or in kind | 56.37 Cr | 44.93 Cr | 52 Cr | 58 Cr |
| Advance income tax and TDS | 2.59 Cr | 76 Lk | 0 | 25 Cr |
| Inter corporate deposits | 0 | 0 | 325 Cr | 0 |
| Total Current Assets | 6645.71 Cr | 8745.01 Cr | 8160 Cr | 6358 Cr |
| Net Current Assets (Including Current Investments) | 2182.35 Cr | 1648.98 Cr | 3256 Cr | 303 Cr |
| Total Assets | 28337.2 Cr | 33843.1 Cr | 34940 Cr | 36711 Cr |
| Contingent Liabilities | 1062.11 Cr | 1738.15 Cr | 1826 Cr | 1834 Cr |
| Total Debt | 6743.93 Cr | 6802.63 Cr | 6083 Cr | 5064 Cr |
| Book Value | 560.92 | 0 | 773.37 | 872.2 |
| Adjusted Book Value | 560.92 | 716.47 | 773.37 | 872.2 |
STANDALONE BALANCE SHEET FOR TATA CHEMICALS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 254.82 Cr | 254.82 Cr | 255 Cr | 255 Cr |
| Equity - Authorised | 270 Cr | 270 Cr | 270 Cr | 270 Cr |
| Equity - Issued | 254.84 Cr | 254.84 Cr | 255 Cr | 255 Cr |
| Equity Paid Up | 254.76 Cr | 254.76 Cr | 255 Cr | 255 Cr |
| Equity Shares Forfeited | 6 Lk | 6 Lk | 0 | 0 |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 13002.3 Cr | 15087.5 Cr | 15737 Cr | 18470 Cr |
| Securities Premium | 1258.21 Cr | 1258.21 Cr | 1258 Cr | 1258 Cr |
| Capital Reserves | 1522.74 Cr | 1522.74 Cr | 1523 Cr | 1523 Cr |
| Profit & Loss Account Balance | 6078.31 Cr | 6642.21 Cr | 7357 Cr | 7798 Cr |
| General Reserves | 1411.94 Cr | 1411.94 Cr | 1412 Cr | 1412 Cr |
| Reserve excluding Revaluation Reserve | 13002.3 Cr | 15087.5 Cr | 15737 Cr | 18470 Cr |
| Shareholder's Funds | 13257.2 Cr | 15342.3 Cr | 15992 Cr | 18725 Cr |
| Deferred Tax Assets / Liabilities | 201.93 Cr | 396.98 Cr | 390 Cr | 743 Cr |
| Deferred Tax Assets | 17.89 Cr | 33.66 Cr | 34 Cr | 53 Cr |
| Deferred Tax Liability | 219.82 Cr | 430.64 Cr | 424 Cr | 796 Cr |
| Other Long Term Liabilities | 15.46 Cr | 13.69 Cr | 14 Cr | 95 Cr |
| Long Term Provisions | 151.85 Cr | 132.84 Cr | 139 Cr | 152 Cr |
| Total Non-Current Liabilities | 369.24 Cr | 543.51 Cr | 543 Cr | 990 Cr |
| Trade Payables | 481.65 Cr | 560.89 Cr | 698 Cr | 562 Cr |
| Sundry Creditors | 481.65 Cr | 560.89 Cr | 485 Cr | 318 Cr |
| Acceptances | 0 | 0 | 213 Cr | 244 Cr |
| Other Current Liabilities | 217.63 Cr | 245.07 Cr | 331 Cr | 355 Cr |
| Advances received from customers | 4.07 Cr | 10.11 Cr | 7 Cr | 11 Cr |
| Interest Accrued But Not Due | 0 | 0 | 4 Cr | 0 |
| Current maturity - Others | 4.1 Cr | 0 | 0 | 0 |
| Short Term Borrowings | 0 | 0 | 0 | 30 Cr |
| Secured ST Loans repayable on Demands | 0 | 0 | 0 | 20 Cr |
| Working Capital Loans- Sec | 0 | 0 | 0 | 20 Cr |
| Short Term Provisions | 339.59 Cr | 325.31 Cr | 324 Cr | 125 Cr |
| Provision for Tax | 135.41 Cr | 106.56 Cr | 91 Cr | 21 Cr |
| Provision for post retirement benefits | 6.01 Cr | 6.36 Cr | 7 Cr | 7 Cr |
| Total Current Liabilities | 1038.87 Cr | 1131.27 Cr | 1353 Cr | 1072 Cr |
| Total Liabilities | 14665.3 Cr | 17017.1 Cr | 17888 Cr | 20787 Cr |
| Gross Block | 3136.56 Cr | 3255.95 Cr | 3838 Cr | 5155 Cr |
| Less: Accumulated Depreciation | 745.22 Cr | 934.15 Cr | 1148 Cr | 1399 Cr |
| Net Block | 2391.34 Cr | 2321.8 Cr | 2690 Cr | 3756 Cr |
| Capital Work in Progress | 420.62 Cr | 1201.6 Cr | 1561 Cr | 1362 Cr |
| Non Current Investments | 8110.07 Cr | 9867 Cr | 9732 Cr | 12938 Cr |
| Long Term Investment | 8110.07 Cr | 9867 Cr | 9732 Cr | 12938 Cr |
| Quoted | 3264.28 Cr | 4984.77 Cr | 4844 Cr | 7628 Cr |
| Unquoted | 4962.13 Cr | 4998.57 Cr | 4888 Cr | 5313 Cr |
| Long Term Loans & Advances | 863.84 Cr | 762.1 Cr | 858 Cr | 917 Cr |
| Other Non Current Assets | 3.48 Cr | 14.09 Cr | 11 Cr | 13 Cr |
| Total Non-Current Assets | 11789.4 Cr | 14170 Cr | 14906 Cr | 19047 Cr |
| Currents Investments | 1281.81 Cr | 1113.35 Cr | 1049 Cr | 368 Cr |
| Quoted | 0 | 0 | 39 Cr | 0 |
| Unquoted | 4962.13 Cr | 4998.57 Cr | 4888 Cr | 5313 Cr |
| Inventories | 521.64 Cr | 879.74 Cr | 1203 Cr | 939 Cr |
| Raw Materials | 290.61 Cr | 634.91 Cr | 860 Cr | 649 Cr |
| Work-in Progress | 29.55 Cr | 43.73 Cr | 25 Cr | 40 Cr |
| Finished Goods | 56.2 Cr | 97.38 Cr | 203 Cr | 161 Cr |
| Stores and Spare | 66.66 Cr | 72.44 Cr | 72 Cr | 73 Cr |
| Sundry Debtors | 144.92 Cr | 181.7 Cr | 201 Cr | 232 Cr |
| Debtors more than Six months | 56.93 Cr | 54.61 Cr | 55 Cr | 54 Cr |
| Debtors Others | 144.92 Cr | 179.23 Cr | 199 Cr | 231 Cr |
| Cash and Bank | 685.32 Cr | 492.94 Cr | 85 Cr | 52 Cr |
| Balances at Bank | 685.32 Cr | 492.94 Cr | 85 Cr | 52 Cr |
| Other Current Assets | 159.86 Cr | 154.65 Cr | 106 Cr | 120 Cr |
| Interest accrued on Investments | 11.91 Cr | 12.31 Cr | 14 Cr | 5 Cr |
| Prepaid Expenses | 6.76 Cr | 5.04 Cr | 9 Cr | 16 Cr |
| Short Term Loans and Advances | 82.36 Cr | 24.71 Cr | 338 Cr | 23 Cr |
| Advances recoverable in cash or in kind | 82.24 Cr | 24.58 Cr | 13 Cr | 23 Cr |
| Inter corporate deposits | 0 | 0 | 325 Cr | 0 |
| Total Current Assets | 2875.91 Cr | 2847.09 Cr | 2982 Cr | 1734 Cr |
| Net Current Assets (Including Current Investments) | 1837.04 Cr | 1715.82 Cr | 1629 Cr | 662 Cr |
| Total Assets | 14665.3 Cr | 17017.1 Cr | 17888 Cr | 20787 Cr |
| Contingent Liabilities | 2483.55 Cr | 2178.58 Cr | 742 Cr | 2182 Cr |
| Total Debt | 4.1 Cr | 0 | 0 | 30 Cr |
| Book Value | 520.38 | 602.22 | 627.14 | 734.31 |
| Adjusted Book Value | 520.38 | 602.22 | 627.14 | 734.31 |
FINANCIAL RATIOS (CONSOLIDATED) FOR TATA CHEMICALS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 10.06 | 49.36 | 90.86 | 10.51 |
| CEPS(Rs) | 45.92 | 77.73 | 131.14 | 56.04 |
| DPS(Rs) | 10 | 12.5 | 17.5 | 15 |
| Book NAV/Share(Rs) | 560.92 | 716.47 | 773.37 | 872.2 |
| Tax Rate(%) | 32.51 | 18.5 | 10.51 | 45.9 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 13.6 | 17.22 | 21.61 | 17.31 |
| EBIT Margin(%) | 8.85 | 13.05 | 17.79 | 8.27 |
| Pre Tax Margin(%) | 5.52 | 10.78 | 15.5 | 5.05 |
| PAT Margin (%) | 3.72 | 8.79 | 13.87 | 2.73 |
| Cash Profit Margin (%) | 10.61 | 14.82 | 18.91 | 8.69 |
| Performance Ratios | ||||
| ROA(%) | 1.47 | 3.78 | 7.13 | 1.25 |
| ROE(%) | 3.02 | 7.22 | 12.91 | 2.14 |
| ROCE(%) | 4.71 | 7.58 | 12.37 | 5.12 |
| Asset Turnover(x) | 0.39 | 0.43 | 0.51 | 0.46 |
| Sales/Fixed Asset(x) | 0.6 | 0.69 | 0.84 | 0.71 |
| Working Capital/Sales(x) | 5.05 | 8.1 | 5.43 | 54.29 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 1.67 | 1.45 | 1.19 | 1.41 |
| Receivable days | 49.25 | 45.5 | 47.06 | 50.22 |
| Inventory Days | 58.83 | 54.37 | 49.81 | 56.09 |
| Payable days | 68.43 | 285.62 | 268.44 | 301.15 |
| Valuation Parameters | ||||
| PER(x) | 74.65 | 19.74 | 10.7 | 102.82 |
| PCE(x) | 16.36 | 12.54 | 7.41 | 19.28 |
| Price/Book(x) | 1.34 | 1.36 | 1.26 | 1.24 |
| Yield(%) | 1.33 | 1.28 | 1.8 | 1.39 |
| EV/Net Sales(x) | 2.4 | 2.4 | 1.8 | 2.07 |
| EV/Core EBITDA(x) | 14.1 | 11.84 | 7.48 | 10.21 |
| EV/EBIT(x) | 25.08 | 17.39 | 9.6 | 23.51 |
| EV/CE(x) | 0.86 | 0.9 | 0.86 | 1.17 |
| M Cap / Sales | 1.88 | 1.97 | 1.48 | 1.79 |
| Growth Ratio | ||||
| Net Sales Growth(%) | -1.52 | 23.75 | 33.01 | -8.15 |
| Core EBITDA Growth(%) | -23.24 | 47.54 | 57.75 | -22.45 |
| EBIT Growth(%) | -87.36 | 78.6 | 59.7 | -56.77 |
| PAT Growth(%) | -94.3 | 185.96 | 75.14 | -81.69 |
| EPS Growth(%) | -96.34 | 390.55 | 84.18 | -88.43 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.47 | 0.37 | 0.31 | 0.23 |
| Current Ratio(x) | 1.49 | 1.23 | 1.66 | 1.05 |
| Quick Ratio(x) | 1.11 | 0.91 | 1.15 | 0.63 |
| Interest Cover(x) | 2.66 | 5.76 | 7.75 | 2.57 |
| Total Debt/Mcap(x) | 0.35 | 0.27 | 0.25 | 0.18 |
FINANCIAL RATIOS (STANDALONE) FOR TATA CHEMICALS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 18.81 | 30.87 | 40.27 | 35.14 |
| CEPS(Rs) | 26.55 | 39.6 | 49.88 | 46.71 |
| DPS(Rs) | 10 | 12.5 | 17.5 | 15 |
| Book NAV/Share(Rs) | 520.38 | 602.22 | 627.14 | 734.31 |
| Tax Rate(%) | 21.97 | 20.36 | 18.81 | 11.81 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 19.48 | 24.72 | 8.32 | 19.14 |
| EBIT Margin(%) | 20.17 | 26.34 | 25.8 | 23.49 |
| Pre Tax Margin(%) | 19.58 | 25.84 | 25.28 | 22.41 |
| PAT Margin (%) | 15.28 | 20.57 | 20.53 | 19.76 |
| Cash Profit Margin (%) | 21.57 | 26.39 | 25.42 | 26.27 |
| Performance Ratios | ||||
| ROA(%) | 3.41 | 4.96 | 5.88 | 4.63 |
| ROE(%) | 3.8 | 5.5 | 6.56 | 5.16 |
| ROCE(%) | 5.01 | 7.04 | 8.24 | 6.13 |
| Asset Turnover(x) | 0.22 | 0.24 | 0.29 | 0.23 |
| Sales/Fixed Asset(x) | 1.04 | 1.2 | 1.41 | 1.01 |
| Working Capital/Sales(x) | 1.71 | 2.23 | 3.07 | 6.85 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 0.96 | 0.84 | 0.71 | 0.99 |
| Receivable days | 16.57 | 15.59 | 13.97 | 17.43 |
| Inventory Days | 71.16 | 66.9 | 75.98 | 86.22 |
| Payable days | 78.89 | 204.25 | 164.27 | 131.67 |
| Valuation Parameters | ||||
| PER(x) | 39.95 | 31.57 | 24.14 | 30.75 |
| PCE(x) | 28.29 | 24.61 | 19.49 | 23.14 |
| Price/Book(x) | 1.44 | 1.62 | 1.55 | 1.47 |
| Yield(%) | 1.33 | 1.28 | 1.8 | 1.39 |
| EV/Net Sales(x) | 6.15 | 6.54 | 5.01 | 6.28 |
| EV/Core EBITDA(x) | 22.24 | 19.79 | 16.08 | 21.89 |
| EV/EBIT(x) | 29.17 | 24.17 | 19.14 | 25.85 |
| EV/CE(x) | 1.26 | 1.43 | 1.38 | 1.47 |
| M Cap / Sales | 6.38 | 6.67 | 5.03 | 6.29 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 2.69 | 24.08 | 32.49 | -11.08 |
| Core EBITDA Growth(%) | -19.19 | 48.1 | 24.98 | -18.1 |
| EBIT Growth(%) | -90.97 | 59.14 | 28.2 | -17.51 |
| PAT Growth(%) | -93 | 64.16 | 30.5 | -12.76 |
| EPS Growth(%) | -93 | 64.16 | 30.5 | -12.76 |
| Financial Stability Ratios | ||||
| Current Ratio(x) | 2.77 | 2.52 | 2.2 | 1.62 |
| Quick Ratio(x) | 2.27 | 1.74 | 1.31 | 0.74 |
| Interest Cover(x) | 33.76 | 52.22 | 49.65 | 21.73 |
SHARE HOLDING PATTERN FOR TATA CHEMICALS LIMITED
| Date | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters % | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 | 37.98 |
| FII % | 14.99 | 14.92 | 14.43 | 14.59 | 14.47 | 14.16 | 14.07 | 13.84 | 13.76 | 13.56 |
| DII % | 0.04 | 0.02 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public % | 27.86 | 27.65 | 28.58 | 27.65 | 27.63 | 26.92 | 27.48 | 28.19 | 28.32 | 28.09 |
PEER COMPARISON FOR TATA CHEMICALS LIMITED
CORPORATE ACTIONS FOR TATA CHEMICALS
| Exchange Date | Purpose | Book Closure Dates |
|---|---|---|
| BSE 10-Oct-2024 | Board Meeting - Quarterly Results | 17-Oct-2024 |
| BSE 19-Jul-2024 | Board Meeting - Quarterly Results | 05-Aug-2024 |
| BSE 29-Apr-2024 | Dividend - Rs.15.0000 per share(150%)Final Dividend | |
| BSE 19-Apr-2024 | Board Meeting - Final Dividend & Audited Results | 29-Apr-2024 |
| BSE 23-Jan-2024 | Board Meeting - Quarterly Results | 05-Feb-2024 |
| BSE 23-Oct-2023 | Board Meeting - Quarterly Results | 10-Nov-2023 |
| BSE 25-Jul-2023 | Board Meeting - Quarterly Results | 07-Aug-2023 |
| BSE 16-May-2023 | Book Closure - Rs.17.5000 per share(175%)Final Dividend & A.G.M. | 15-Jun-2023 26-Jun-2023 |
| BSE 16-May-2023 | AGM - Rs.17.5000 per share(175%)Final Dividend & A.G.M. | 26-Jun-2023 26-Jun-2023 |
| BSE 03-May-2023 | Dividend - Rs.17.5000 per share(175%)Final Dividend | |
| BSE 21-Apr-2023 | Board Meeting - Final Dividend & Audited Results | 03-May-2023 |
| BSE 20-Jan-2023 | Board Meeting - Quarterly Results | 01-Feb-2023 |
| BSE 17-Oct-2022 | Board Meeting - Quarterly Results | 27-Oct-2022 |
| BSE 29-Jul-2022 | Board Meeting - Quarterly Results | 09-Aug-2022 |
| BSE 15-Jun-2022 | Dividend - Rs.12.5000 per share(125%)Final Dividend | |
| BSE 29-Apr-2022 | Book Closure - Rs.12.5000 per share(125%)Final Dividend & A.G.M. | 17-Jun-2022 22-Jun-2022 |
| BSE 29-Apr-2022 | AGM - Rs.12.5000 per share(125%)Final Dividend & A.G.M. | 06-Jul-2022 22-Jun-2022 |
| BSE 20-Apr-2022 | Board Meeting - Audited Results | 29-Apr-2022 |
| BSE 31-Jan-2022 | Board Meeting - Quarterly Results | 10-Feb-2022 |
| BSE 19-Oct-2021 | Board Meeting - Quarterly Results | 27-Oct-2021 |
CORPORATE ANNOUNCEMENTS FOR TATA CHEMICALS
| Exchange Date | Category File | Description |
|---|---|---|
| BSE 31-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
| BSE 29-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of the SEBI (LODR) Regulations 2015. |
| BSE 24-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of the SEBI (LODR) Regulations 2015 |
| BSE 24-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Earnings Call Transcript Transcript of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30 2024 |
| BSE 22-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of the SEBI (LODR) Regulations 2015. |
| BSE 18-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Re-scheduled Analyst/Institutional Investor Meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
| BSE 18-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of the SEBI (LODR) Regulations 2015. |
| BSE 18-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Advertisement - Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ended September 30 2024 |
| BSE 17-Oct-2024 | General Announcements FILE | Audio Recording Of Analysts/Investors Call Pertaining To The Financial Results For The Second Quarter And Half Year Ended September 30 2024 Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30 2024 |
| BSE 17-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Investor Presentation Submission of Analysts / Investor Presentation on the Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half year ended September 30 2024 |
| BSE 17-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release Press Release - Unaudited Consolidated and Audited Standalone Financial results for the second quarter and half year ended September 30 2024 |
| BSE 17-Oct-2024 | Outcome FILE | Board Meeting Outcome for Financial Results For The Second Quarter And Half Year Ended September 30 2024 Financial Results for the second quarter and half year ended September 30 2024 |
| BSE 17-Oct-2024 | Outcome FILE | Results - Financial Results For Second Quarter And Half Year Ended September 30 2024 Financial Results for second quarter and half year ended September 30 2024 |
| BSE 15-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of the SEBI (LODR) Regulations 2015. |
| BSE 11-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of the SEBI (LODR) Regulations 2015. |
| BSE 10-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Analyst/Investors Call under the SEBI (LODR) Regulations 2015. |
| BSE 10-Oct-2024 | Intimation FILE | Board Meeting Intimation for Considering And Approving The Unaudited Consolidated And Audited Standalone Financial Results Of The Company For The Second Quarter And Half Year Ended September 30 2024. TATA CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2024 inter alia to consider and approve the Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half year ended September 30 2024.In accordance with the Tata Code of Conduct for Prevention of Insider Trading pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations 2015 the Company has intimated its Designated Persons regarding the closure of the trading window from Tuesday September 24 2024 to Saturday October 19 2024 (both days inclusive).This is for your information and records. |
| BSE 10-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of the SEBI (LODR) Regulations 2015. |
| BSE 08-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Credit Rating Re-affirmation of Credit rating by CARE Ratings Limited |
| BSE 08-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of the SEBI (LODR) Regulations 2015. |
| BSE 04-Oct-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regualtions 2018 for the quarter ended September 30 2024. |
| BSE 04-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of the SEBI (LODR) Regulations 2015. |
| BSE 01-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Sub: Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
| BSE 27-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Change in Management Pursuant to Regulation 30 of the SEBI Listing Regulations 2015 we wish to inform you of the change in Senior Management Personnel of the Company. |
| BSE 27-Sep-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Sub: Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
| BSE 26-Sep-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of the SEBI (LODR) Regulations 2015. |
| BSE 24-Sep-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Sub: Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
| BSE 20-Sep-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of the SEBI (LODR) Regulations 2015 |
| BSE 13-Sep-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Sub: Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
| BSE 12-Sep-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Sub: Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
INSIDER TRADING FOR TATA CHEMICALS
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| No Insider trading details found | |||
BULK BLOCK DEALS FOR TATA CHEMICALS LIMITED
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 27-Feb-2024 | Sell BLOCK | 243,275 @ 968.15 | JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITED |
| BSE 27-Feb-2024 | Buy BLOCK | 243,275 @ 968.15 | THE JUPITER GLOBAL FUND-JUPITER INDIA SELECT |
| BSE 25-Oct-2022 | Sell BLOCK | 127,732 @ 1156.75 | ISHARES CORE EMERGING MARKETS MAURITIUS CO |
| BSE 25-Oct-2022 | Buy BLOCK | 127,732 @ 1156.75 | ISHARES CORE MSCI EMERGING MARKETS ETF |
| BSE 25-Oct-2022 | Sell BLOCK | 84,270 @ 1156.75 | ISHARES INDIA SC MAURITIUS COMPANY |
| BSE 25-Oct-2022 | Buy BLOCK | 84,270 @ 1156.75 | ISHARES MSCI INDIA SMALL-CAP ETF |
| BSE 17-Oct-2022 | Sell BLOCK | 200,728 @ 1143.70 | ISHARES CORE EMERGING MARKETS MAURITIUS CO |
| BSE 17-Oct-2022 | Buy BLOCK | 200,728 @ 1143.70 | ISHARES CORE MSCI EMERGING MARKETS ETF |
| BSE 17-Oct-2022 | Sell BLOCK | 28,071 @ 1143.70 | ISHARES INDIA SC MAURITIUS COMPANY |
| BSE 17-Oct-2022 | Buy BLOCK | 28,071 @ 1143.70 | ISHARES MSCI INDIA SMALL-CAP ETF |
| BSE 11-Oct-2022 | Sell BLOCK | 196,282 @ 1199.65 | ISHARES CORE EMERGING MARKETS MAURITIUS CO |
| BSE 11-Oct-2022 | Buy BLOCK | 196,282 @ 1199.65 | ISHARES CORE MSCI EMERGING MARKETS ETF |
| BSE 11-Oct-2022 | Sell BLOCK | 27,449 @ 1199.65 | ISHARES INDIA SC MAURITIUS COMPANY |
| BSE 11-Oct-2022 | Buy BLOCK | 27,449 @ 1199.65 | ISHARES MSCI INDIA SMALL-CAP ETF |
| BSE 19-Sep-2022 | Sell BLOCK | 132,442 @ 1105.75 | ISHARES CORE EMERGING MARKETS MAURITIUS CO |
| BSE 19-Sep-2022 | Buy BLOCK | 132,442 @ 1105.75 | ISHARES CORE MSCI EMERGING MARKETS ETF |
| BSE 19-Sep-2022 | Sell BLOCK | 18,522 @ 1105.75 | ISHARES INDIA SC MAURITIUS COMPANY |
| BSE 19-Sep-2022 | Buy BLOCK | 18,522 @ 1105.75 | ISHARES MSCI INDIA SMALL-CAP ETF |
| BSE 04-May-2022 | Buy BLOCK | 265,929 @ 1033.00 | ISHARES CORE MSCI TOTAL INTERNATIONAL STOCK ETF |
| BSE 04-May-2022 | Sell BLOCK | 265,929 @ 1033.00 | ISHARES CORE TOTAL INTERNATIONAL STOCK MAURITIUS CO |
DIVIDEND BY TATA CHEMICALS LIMITED
| Ex Dividend Date | Dividend Type | Dividend |
|---|---|---|
| 12-Jun-2024 | DIVIDEND | 15 |
| 14-Jun-2023 | DIVIDEND | 17.5 |
| 15-Jun-2022 | DIVIDEND | 12.5 |
| 14-Jun-2021 | DIVIDEND | 10 |
SPLIT / BONUS BY TATA CHEMICALS LIMITED
No Split / Bonus details found
Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed